Matsumoto K, Ogawa H, Kusama T, Nagase O, Sawaki N, Inage M, Kusumoto S, Shiba T, Azuma I
Infect Immun. 1981 May;32(2):748-58. doi: 10.1128/iai.32.2.748-758.1981.
The experimental system utilized in investigating the correlation between the chemical structures of muramyl peptides and their protective activities in the sepsis type of systemic infections caused by Escherichia coli was applied in evaluating the enhancement of resistance to infection induced by 32 synthetic glycopeptide analogs, including 6-O-acyl derivatives and 1-alpha-O-benzyl derivatives of muramyl dipeptide (N-acetyl muramyl-L-alanyl-D-isoglutamine). In assessing the 6-O-acyl derivatives of muramyl dipeptide, we found that the degree of protective activity was attributable to the kinds of fatty acids introduced. Acylation of the 6-hydroxy group on the muramic acid moiety in muramyl dipeptide with natural mycolic acid or a synthetic fatty acid possessing either an alpha-branched or an alpha-branched, beta-hydroxylated group resulted in a decrease in or a disappearance of the protective activity of muramyl dipeptide. Acylation with a normal fatty acid or an iso fatty acid resulted in a retention or enhancement of muramyl dipeptide activity. The activity of acylated derivatives containing linear fatty acids was stimulated by increasing the chain length up to 18 carbon atoms. The highest degree of protective activity occurred with the derivatives acylated with straight-chain fatty acids, particularly with the derivatives acylated with palmitic acid and arachidic acid. Benzylation of the 1-hydroxy group of muramyl dipeptide resulted in a decrease in or a loss of protective activity.
在研究胞壁酰肽的化学结构与其在大肠杆菌引起的败血症型全身感染中的保护活性之间的相关性时所使用的实验系统,被用于评估32种合成糖肽类似物诱导的抗感染能力增强情况,这些类似物包括胞壁酰二肽(N - 乙酰胞壁酰 - L - 丙氨酰 - D - 异谷氨酰胺)的6 - O - 酰基衍生物和1 - α - O - 苄基衍生物。在评估胞壁酰二肽的6 - O - 酰基衍生物时,我们发现保护活性的程度归因于所引入的脂肪酸种类。用天然分枝菌酸或具有α - 分支或α - 分支、β - 羟基化基团的合成脂肪酸对胞壁酰二肽中胞壁酸部分的6 - 羟基进行酰化,会导致胞壁酰二肽的保护活性降低或消失。用正常脂肪酸或异脂肪酸进行酰化会导致胞壁酰二肽活性的保留或增强。含有直链脂肪酸的酰化衍生物的活性随着链长增加至18个碳原子而受到刺激。保护活性最高的是用直链脂肪酸酰化的衍生物,特别是用棕榈酸和花生酸酰化的衍生物。胞壁酰二肽1 - 羟基的苄基化会导致保护活性降低或丧失。